![Hanne Evenbratt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Hanne Evenbratt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cline Scientific AB
![]() Cline Scientific AB BiotechnologyHealth Technology Cline Scientific AB engages in the development and marketing of biomedical products for stem cell and cancer research. It offers nano gradient surfaces, nano surfaces, gold nanoparticles, and silver nanoparticles. The company was founded by Niklas Holmquist, Jenny Lindström, and Anders Patrik Sundh on September 26, 2011 and is headquartered in Gothenburg, Sweden. | Directeur Technique/Scientifique/R&D | 09/03/2022 | - |
Corporate Officer/Principal | - | 09/03/2022 | |
Liv Diagnostics AB
![]() Liv Diagnostics AB BiotechnologyHealth Technology Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden. | Directeur/Membre du Conseil | 01/01/2016 | - |
Fondateur | 01/01/2016 | - | |
Formu Consulting AB | Corporate Officer/Principal | - | - |
Historique de carrière de Hanne Evenbratt
Formation de Hanne Evenbratt
Chalmers University of Technology | Doctorate Degree |
Statistiques
Internationale
Suède | 5 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
![]() | Health Technology |
Entreprise privées | 2 |
---|---|
Liv Diagnostics AB
![]() Liv Diagnostics AB BiotechnologyHealth Technology Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden. | Health Technology |
Formu Consulting AB |
- Bourse
- Insiders
- Hanne Evenbratt
- Expérience